What’s Next: “We know from published literature that long COVID can result in fatigue, headache and attention disorder,” said Andrea DeVries, staff vice president for Health Services Research at Elevance Health and the lead author of the study. “While those conditions are concerning, the results from this study point to even more worrisome outcomes that can severely impact quality and length of life for individuals with long COVID.”
“While we have made impressive strides in our ability to prevent and treat COVID-19, this study points to the need for care management programs like those developed by Elevance Health to better identify and help individuals at high risk for long COVID,” said Jennifer Kowalski, vice president of the Elevance Health Public Policy Institute. “From a policy perspective, these results can inform understanding of future health care utilization, labor force participation and analysis of public program spending and outcomes.”
Methodology: This case-control study included members of commercial health plans and used national insurance claims data enhanced with laboratory results and mortality data from the Social Security Administration’s Death Master File and Datavant Flatiron data. The study sample consisted of 13,435 adults meeting a claims-based definition for PCC with a control cohort of 26,870 adults with no evidence of COVID-19 from April 1, 2020, to July 31, 2021.
Read the Study: